Last quarter (Q ), Addex Therapeutics's total revenue was CHF―, a decrease of -100.00% from the same quarter last year. In Q, Addex Therapeutics's net income was CHF―. See Addex Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	CHF 592.77K	CHF 1.65M	CHF 1.42M	CHF 2.92M	CHF 3.61M	CHF 2.76M
Cost of Revenue	-	-	CHF -21.97M	-	-	-
Gross Profit	-	CHF 1.65M	CHF 1.42M	CHF 2.92M	-	-
Operating Expense	CHF 11.85M	CHF 11.89M	CHF 22.28M	CHF 18.72M	CHF 15.86M	CHF 17.37M
Operating Income	CHF -11.26M	CHF -10.25M	CHF -20.86M	CHF -15.81M	CHF -12.24M	CHF -14.60M
Net Non Operating Interest Income Expense	CHF -14.91K	CHF 6.79K	CHF 29.25K	CHF 217.01K	CHF -34.20K	CHF -91.64K
Other Income Expense	CHF -54.79K	-	CHF -22.52K	CHF -497.55K	CHF -581.13K	CHF -84.80K
Pretax Income	CHF -11.33M	CHF -10.56M	CHF -20.80M	CHF -15.35M	CHF -12.86M	CHF -14.78M
Tax Provision	-	-	-	-	CHF 0.00	CHF 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	CHF -11.33M	CHF -10.56M	CHF -19.53M	CHF -15.09M	CHF -12.86M	CHF -14.78M
Basic EPS	CHF -0.28	CHF -0.14	CHF -0.46	CHF -0.45	CHF -0.48	CHF -0.56
Diluted EPS	CHF -0.28	CHF -0.14	CHF -0.46	CHF -0.45	CHF -0.48	CHF -0.56
Basic Average Shares	CHF 85.25M	CHF 74.31M	CHF 45.18M	CHF 33.54M	CHF 26.68M	CHF 26.43M
Diluted Average Shares	CHF 85.25M	CHF 74.31M	CHF 42.47M	CHF 33.54M	CHF 26.68M	CHF 26.43M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	CHF 10.96K	-	-	-	CHF 12.00K	CHF 0.00
Total Expenses	CHF 11.85M	CHF 11.89M	CHF 313.26K	CHF 18.72M	CHF 15.86M	CHF 17.37M
Net Income From Continuing And Discontinued Operation	CHF -11.33M	CHF -10.56M	CHF -19.53M	CHF -15.09M	CHF -12.86M	CHF -14.78M
Normalized Income	CHF -11.27M	CHF -7.76M	-	-	CHF -12.28M	CHF -14.70M
Interest Expense	CHF 18.72K	-	-	-	CHF 69.50K	CHF 128.52K
EBIT	CHF -11.31M	CHF -10.50M	CHF -20.83M	CHF -15.39M	CHF -12.79M	CHF -14.65M
EBITDA	CHF -11.15M	CHF -10.19M	CHF -20.51M	CHF -15.04M	CHF -12.41M	CHF -14.32M

Currency in CHF

Addex Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing